Green Thumb Industries (GTBIF) Current Assets (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Current Assets came in at $673.8 million in Q1 2026, up 51.46% YoY from $444.9 million in Q1 2025, and up 16.75% on a QoQ basis from $577.2 million in Q4 2025.
Green Thumb Industries (GTBIF) Current Assets (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Current Assets data on file, last reported at $673.8 million in Q1 2026.
- Quarterly Current Assets rose 51.46% year-over-year to $673.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $673.8 million (up 51.46% YoY) and the FY2025 annual result came in at $577.2 million, up 42.9% from the prior year.
- Current Assets improved to $673.8 million in Q1 2026, from $577.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $673.8 million in Q1 2026 to a low of $311.5 million in Q2 2022.
- A 5-year average of $404.1 million and a median of $391.9 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets slumped 35.32% — and 2026, when it surged 51.46%.
- Tracing GTBIF's Current Assets over 5 years: stood at $351.4 million in 2022, then dropped by 2.44% to $342.8 million in 2023, then increased by 17.84% to $403.9 million in 2024, then soared by 42.9% to $577.2 million in 2025, then grew by 16.75% to $673.8 million in 2026.
- The last three Current Assets figures came in at $673.8 million (Q1 2026), $577.2 million (Q4 2025), and $477.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.22 Bn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 624.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 624.32 Mn |
| Mar 31, 2026 | 673.85 Mn |
| Dec 31, 2025 | 577.17 Mn |
| Sep 30, 2025 | 477.46 Mn |
| Jun 30, 2025 | 405.44 Mn |
| Mar 31, 2025 | 444.91 Mn |
| Dec 31, 2024 | 403.90 Mn |
| Sep 30, 2024 | 391.87 Mn |
| Jun 30, 2024 | 403.80 Mn |
| Mar 31, 2024 | 419.69 Mn |
| Dec 31, 2023 | 342.76 Mn |
| Sep 30, 2023 | 320.18 Mn |
| Jun 30, 2023 | 341.25 Mn |
| Mar 31, 2023 | 357.61 Mn |
| Dec 31, 2022 | 351.35 Mn |
| Sep 30, 2022 | 318.56 Mn |
| Jun 30, 2022 | 311.53 Mn |
| Mar 31, 2022 | 328.36 Mn |
| Dec 31, 2021 | 364.23 Mn |
| Sep 30, 2021 | 420.75 Mn |